Concepedia

Author

Michael Lampa

Harvard University

Also Known As

M. LAMPA, Michael J. G. Lampa, Michael Lampa

17

Publications

602

Citations

7

H-Index

24

Concepts

All Affiliations

Harvard UniversityBoston Children's HospitalDana-Farber Cancer InstituteBrigham and Women's HospitalUniversity of Bergen
ML

About

Michael Lampa is an author at Harvard University specializing in medicine, hematology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

432

2

Public Health

1

1

203

3

Biochemistry

1

1

156

4

Cell Biology

1

1

156

5

Metabolism

1

1

156

Michael Lampa

×

6

Publications

592

Citations

6

H-Index

YearCitations

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function

Andrew L. Frelinger, Deepak L. Bhatt, Ronald Lee,

Journal of the American College of Cardiology

2013

203

Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition

Michael Lampa, Heike Arlt, Timothy He,

PLoS ONE

2017

156

Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer

Oddbjørn Straume, Takeshi Shimamura, Michael Lampa,

Proceedings of the National Academy of Sciences

2012

130

Effects of in vitro adult platelet transfusions on neonatal hemostasis

Francisca Ferrer‐Marín, Chaitanya Chavda, Michael Lampa,

Journal of Thrombosis and Haemostasis

2011

73

Spontaneous Reversion of the Angiogenic Phenotype to a Nonangiogenic and Dormant State in Human Tumors

Michael S. Rogers, Katherine B. Novak, David Zurakowski,

Molecular Cancer Research

2014

20

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Non-Compliance, Diet, Smoking, Co-Medications (including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function

Andrew L. Frelinger, Deepak L. Bhatt, Ronald Lee,

Blood

2012

10

Page 1